Transduced PEP-1-heme oxygenase-1 fusion protein reduces remote organ injury induced by intestinal ischemia/reperfusion

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 1057-1065

  He, Xiang Hu ^a   Li, Qing Wen ^a   Wang, Yan Lin ^a   Zhang, Zong Ze ^a   Ke, Jian Juan ^a   Yan, Xue Tao ^b   Chen, Kai ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Center for Prenatal Diagnosis   (China)

Author keywords

Cell Penetrating Peptides; Heme Oxygenase 1; Reperfusion Injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CELL PENETRATING PEPTIDE; CYTOKINE; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MALONALDEHYDE; PEP 1 HEME OXYGENASE 1; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HEME OXYGENASE 1; PEP-1-HEME OXYGENASE-1 FUSION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL DEATH; DOSE TIME EFFECT RELATION; GENETIC TRANSDUCTION; HISTOPATHOLOGY; INTESTINE INJURY; INTESTINE ISCHEMIA; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY; WESTERN BLOTTING; ANIMAL; BLOOD; ENZYMOLOGY; GENETICS; INTESTINE; LIVER; LUNG; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; HEME OXYGENASE-1; INTERLEUKIN-6; INTESTINES; LIVER; LUNG; MALE; MALONDIALDEHYDE; NF-KAPPA B; ORGAN SIZE; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84927593372     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893924     Document Type: Article

References (41)

1. Paterno F, Longo WE: The etiology and pathogenesis of vascular disorders of the intestine. Radiol Clin North Am, 2008; 46(5): 877-85
2. Kalia N, Brown NJ, Hopkinson K et al: FK409 inhibits both local and remote organ damage after intestinal ischaemia. J Pathol, 2002; 197(5): 595-602
3. Jing H, Shen G, Wang G et al: MG132 alleviates liver injury induced by intestinal ischemia/reperfusion in rats: involvement of the AhR and NFkB pathways. J Surg Res, 2012; 176(1): 63-73
4. Horie Y, Yamagishi Y, Kato S et al: Low-dose ethanol attenuates gut ischemia?reperfusion-induced liver injury in rats via nitric oxide production. J Gastroenterol Hepatol, 2003; 18(2): 211-17
5. Giakoustidis AE, Giakoustidis DE, Iliadis S et al: Attenuation of intestinal ischemia/reperfusion induced liver and lung injury by intraperitoneal administration of (-)-epigallocatechin-3-gallate. Free Radic Res, 2006; 40(1): 103-10
6. Sizlan A, Guven A, Uysal B et al: Proanthocyanidin protects intestine and remote organs against mesenteric ischemia/reperfusion injury. World J Surg, 2009; 33(7): 1384-91
7. Kubiak BD, Albert SP, Gatto LA et al: Peritoneal negative pressure therapy prevents multiple organ injury in a chronic porcine sepsis andischemia/reperfusion model. Shock, 2010; 34(5): 525-34
8. Ito K, Ozasa H, Horikawa S: Edaravone protects against lung injury induced by intestinal ischemia/reperfusion in rat. Free Radic Biol Med, 2005; 38(3): 369-74
9. Victoni T, Coelho FR, Soares AL et al: Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signalingpathway. Med Microbiol Immunol, 2010; 199(1): 35-42
10. Schramm R, Appel F, Reinacher M et al: Atherosclerosis aggravates ischemia?reperfusion injury in the gut and remote damage in the liver and the lung. Inflamm Res, 2011; 60(6): 555-67
11. Sorkine P, Setton A, Halpern P et al: Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration. Crit Care Med, 1995; 23(8): 1377-81
12. Narita K, Kuwabara Y, Fujii Y: Lung injury after intestinal ischemia-reperfusion may be avoided by the reduced absorption of locally produced cytokines. Surg Today, 2004; 34(11): 937-42
13. Börjesson A, Norlin A, Wang X et al: TNF-alpha stimulates alveolar liquid clearance during intestinal ischemia-reperfusion in rats. Am J Physiol Lung Cell Mol Physiol, 2000; 278(1): L3-12
14. Nichols TC: NF-kappaB and reperfusion injury. Drug News Perspect, 2004; 17(2): 99-104
15. He XH, Wang Y, Yan XT et al: Transduction of PEP-1-heme oxygenase-1 fusion protein reduces myocardial ischemia/reperfusion injury in rats. J Cardiovasc Pharmacol, 2013; 62(5): 436-42
16. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S: Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol, 2010; 80(12): 1895-903
17. Cai C, Teng L, Vu D et al: The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J Biol Chem, 2012; 287(40): 33720-32
18. Blydt-Hansen TD, Katori M, Lassman C et al: Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants fromischemia?reperfusion injury. J Am Soc Nephrol, 2003; 14(3): 745-54
19. Raval CM, Lee PJ: Heme oxygenase-1 in lung disease. Curr Drug Targets, 2010; 11(12): 1532-40
20. He XH, Yan XT, Wang YL et al; Transduced PEP-1-heme oxygenase-1 fusion protein protects against intestinal ischemia/reperfusion injury. J Surg Res, 2014;187(1): 77-84
21. Horie Y, Wolf R, Miyasaka M et al: Leukocyte adhesion and hepatic microvascular responses to intestinal ischemia/reperfusion in rats. Gastroenterology, 1996; 111(3): 666-73
22. Wang J, Qiao L, Li Y, Yang G: Ginsenoside Rb1 attenuates intestinal ischemia-reperfusion-induced liver injury by inhibiting NF-kappaB activation. Exp Mol Med, 2008; 40(6): 686-98
23. Sasaki M, Joh T: Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents. J Clin Biochem Nutr, 2007; 40(1): 1-12
24. Wu J, Hecker JG, Chiamvimonvat N: Antioxidant enzyme gene transfer for ischemic diseases. Adv Drug Deliv Rev, 2009; 61(4): 351-63
25. Takahashi T, Morita K, Akagi R, Sassa S: Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem, 2004; 11(12): 1545-61
26. Tracz MJ, Alam J, Nath KA: Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol, 2007; 18(2): 414-20
27. Melo LG, Agrawal R, Zhang L et al: Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery ofheme oxygenase gene. Circulation, 2002; 105(5): 602-7
28. Ben-Ari Z, Issan Y, Katz Y et al: Induction of heme oxygenase-1 protects mouse liver from apoptotic ischemia/reperfusion injury. Apoptosis, 2013; 18(5): 547-55
29. Ferenbach DA, Ramdas V, Spencer N et al: Macrophages expressing heme oxygenase-1 improve renal function in ischemia/reperfusion injury. Mol Ther, 2010; 18(9): 1706-13
30. Attuwaybi BO, Kozar RA, Moore-Olufemi SD et al: Heme oxygenase-1 induction by hemin protects against gut ischemia/reperfusion injury. J Surg Res, 2004; 118(1): 53-57
31. Ito K, Ozasa H, Kojima N et al: Pharmacological preconditioning protects lung injury induced by intestinal ischemia/reperfusion in rat. Shock, 2003; 19(5): 462-68
32. Zhao HD, Zhang F, Shen G et al: Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway. World J Gastroenterol, 2010; 16(24): 3002-10
33. Souza DG, Cassali GD, Poole S, Teixeira MM: Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusioninjury. Br J Pharmacol, 2001; 134(5): 985-94
34. Souza DG, Soares AC, Pinho V et al: Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury. Am J Pathol, 2002; 160(5): 1755-65
35. Rocourt DV, Mehta VB, Besner GE: Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury. J Surg Res, 2007; 139(2): 269-73
36. Wada K, Montalto MC, Stahl GL: Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology, 2001; 120(1): 126-33
37. Giakoustidis DE, Giakoustidis AE, Iliadis S et al: Attenuation of liver ischemia?reperfusion induced apoptosis by epigallocatechin-3-gallate via downregulation of NF-kappaB and c-Jun expression. J Surg Res, 2010; 159(2): 720-28
38. Zou L, Attuwaybi B, Kone BC: Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol, 2003; 284(4): G713-21
39. Suzuki T, Yamashita K, Jomen W et al: The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats. J Surg Res, 2008; 149(1): 69-75
40. Souza DG, Vieira AT, Pinho V et al: NF-kappaB plays a major role during the systemic and local acute inflammatory response following intestinal reperfusion injury. Br J Pharmacol, 2005; 145(2): 246-54
41. Kim YN, Jung HY, Eum WS et al: Neuroprotective effects of PEP-1-carbonyl reductase 1 against oxidative-stress-induced ischemic neuronal cell damage. Free Radic Biol Med, 2014; 69: 181-96